Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer

European Journal of Cancer

Volumn 45, Issue 4, 2009, Pages 694-704

  Al Bazz, Yousif O ^a   Underwood, James C E ^a   Brown, Barry L ^a   Dobson, Pauline R M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Akt; BAD; Breast cancer; Immunohistochemistry; Phospho Akt

Indexed keywords

ESTROGEN RECEPTOR; PARAFFIN; PROTEIN BAD; PROTEIN KINASE B;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MENOPAUSE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; TUMOR VOLUME;

ADULT; BCL-ASSOCIATED DEATH PROTEIN; BREAST; BREAST NEOPLASMS; CRYOPRESERVATION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; PARAFFIN EMBEDDING; PHOSPHORYLATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 60149096824     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.11.044     Document Type: Article

References (52)

1. Vakkala M., Lahteenmaki K., Raunio H., Paakko P., and Soini Y. Apoptosis during breast carcinoma progression. Clin Cancer Res 5 (1999) 319-324
2. Burgering B.M., and Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376 (1995) 599-602
3. Kandel E.S., and Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253 (1999) 210-229
4. Persad S., Attwell S., Gray V., et al. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97 (2000) 3207-3212
5. Datta S.R., Dudek H., Tao X., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
6. Marte B.M., and Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 9 (1997) 355-358
7. Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385 (1997) 544-548
8. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10 2 (1998) 262-267
9. Bellacosa A., Deo Feo D., Godwin A.K., et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64 (1995) 280-285
10. Klarlund J.K., Guilherme A., Holik J.J., Virbasius J.V., Chawla A., and Czech M.P. Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and Sec7 homology domains. Science 275 (1997) 1927-1930
11. Shtilbans V., Wu M., and Burstein D.E. Current overview of the role of Akt in cancer studies via applied immunohistochemistry. Ann Diagn Pathol 12 (2008) 153-160
12. Sun M., Wang G., Paciga J.E., Feldman R.I., et al. AKT1/PKB{alpha} kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 159 (2001) 431-437
13. Perez-Tenorio G., and Stal O. Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Brit J Cancer 86 (2002) 540-545
14. Tsai E.M., Wang S.C., Lee J.N., and Hung M.C. Akt activation by estrogen in estrogen receptor-negative breast cancer cells. Cancer Res 61 (2001) 8390-8392
15. Bae J., Hsu S.Y., Leo C.P., Zell K., and Hsueh A.J. Underphosphorylated BAD interacts with diverse antiapoptotic Bcl-2 family proteins to regulate apoptosis. Apoptosis 6 (2001) 319-330
16. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., and Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80 (1995) 285-291
17. Zha J., Harada H., Yang E., Jockel J., and Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87 (1996) 619-628
18. Fernando R., Foster J.S., Bible A., et al. Breast cancer cell proliferation is inhibited by BAD: regulation of cyclin D1. J Biol Chem 282 (2007) 28864-28873
19. Datta S.R., Katsov A., Hu L., et al. 14-3-3 Proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6 (2000) 41-51
20. Mok C.L., Gil-Gomez G., Williams O., et al. BAD can act as a key regulator of T cell apoptosis and T cell development. J Exp Med 189 (1999) 575-586
21. Ranger A.M., Zha J., Harada H., et al. Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci USA 100 (2003) 9324-9329
22. Fernando R.I., and Wimalasena J. Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol Biol Cell 15 (2004) 3266-3284
23. Sinicrope F.A., Rego R.L., Foster N.R., et al. Proapoptotic BAD and BID protein expression predict survival in stages II and III colon cancers. Clin Cancer Res 14 (2008) 4128-4133
24. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
25. Nakatani K., Thompson D.A., Barthel A., et al. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 274 (1999) 21528-21532
26. Hsu J.H., Shi Y., Krajewski S., et al. The AKT kinase is activated in multiple myeloma tumor cells. Blood 98 (2001) 2853-2855
27. Alkan S., and Izban K.F. Immunohistochemical localization of phosphorylated AKT in multiple myeloma. Blood 99 (2002) 2278-2279
28. Zinda M.J., Johnson M.A., Paul J.D., et al. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon. Clin Cancer Res 7 (2001) 2475-2479
29. Masure S., Haefner B., Wesselink J.J., et al. Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. Eur J Biochem 265 (1999) 353-360
30. Hutchinson J., Jin J., Cardiff R.D., Woodgett J.R., and Muller W.J. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 21 (2001) 2203-2212
31. McGuire W.L., Clark G.M., Dressler L.G., and Owens M.A. Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monogr 1 (1986) 19-23
32. Song R.X.D., and Santen R.J. Apoptotic action of estrogen. Apoptosis 8 (2003) 55-60
33. Cheng J.Q., Lindsley C.W., Cheng G.Z., Yang H., and Nicosia S.V. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 24 (2005) 7482-7492
34. Panigrahi A.R., Pinder S.E., Chan S.Y., Paish E.C., Robertson J.F., and Ellis I.O. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome. J Pathol 204 (2004) 93-100
35. Kucab J., Lee C., Chen C.S., et al. Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours. Breast Cancer Res 7 (2005) R796-R807
36. Graff J.R., Konicek B.W., McNulty A.M., et al. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. J Biol Chem 275 (2000) 24500-24505
37. Farrelly N., Lee Y.J., Oliver J., Dive C., and Streuli C.H. Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol 144 (1999) 1337-1348
38. Meier R., Alessi D.R., Cron P., and Hemmings B.A. Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase B beta. J Biol Chem 272 (1997) 30491-30497
39. Vestey S.B., Sen C., Calder C.J., Perks C.M., Pignatelli M., and Winters Z.E. Activated Akt expression in breast cancer: correlation with p53, Hdm2 and patient outcome. Eur J Cancer 41 (2005) 1017-1025
40. Muslin A.J., and Xing H. 14-3-3 Proteins: regulation of subcellular localization by molecular interference. Cell Signal 12 (2000) 703-709
41. Wilson J.W., and Potten C.S. Immunohistochemical localization of BAX and BAD in the normal and BCL-2 null gastrointestinal tract. Apoptosis 1 (1996) 183-190
42. Ahmad S., Singh N., and Glazer R.I. Role of AKT1 in 17[beta]-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol 58 (1999) 425-430
43. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., and Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 (2000) 538-541
44. Campbell R.A., Bhat-Nakshatri P., Patel N.M., Constantinidou D., Ali S., and Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha. A new model for anti-estrogen resistance. J Biol Chem 276 (2001) 9817-9824
45. Sun M., Paciga J.E., Feldman R.I., et al. Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor {alpha} (ER{alpha}) via interaction between ER{alpha} and PI3K. Cancer Res 61 (2001) 5985-5991
46. Bernard L., Legay C., Adriaenssens E., Mougel A., and Ricort J.M. Estradiol regulates the insulin-like growth factor-I (IGF-I) signalling pathway: a crucial role of phosphatidylinositol 3-kinase (PI 3-kinase) in estrogens requirement for growth of MCF-7 human breast carcinoma cells. Biochem Biophys Res Commun 350 (2006) 916-921
47. Yuan Z.Q., Sun M., Feldman R.I., et al. Oncogene 19 (2000) 2324-2330
48. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., and Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278 (1997) 687-689
49. Chan T.O., Rittenhouse S.E., and Tsichlis P.N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Ann Rev Biochem 68 (1999) 965-1014
50. Kulik G., Klippel A., and Weber M.J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 17 (1997) 1595-1606
51. Cardone M.H., Roy N., Stennicke H.R., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
52. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev 13 (1999) 2905-2927